ClinicalTrials.Veeva

Menu

Lymphedema Severity on Shoulder Joint Function and Muscle Activation Patterns in Breast Cancer Survivors

A

Ahram Canadian University

Status

Completed

Conditions

Breast Cancer
Breast Cancer Female

Treatments

Other: Lymphedema severity stratification

Study type

Observational

Funder types

Other

Identifiers

NCT05934695
010/28202306

Details and patient eligibility

About

Breast cancer-related lymphedema (BCRL) is a common complication affecting the upper extremity following breast cancer treatment. This study aims to investigate the relationship between lymphedema severity and shoulder joint function and muscle activation patterns in breast cancer survivors.

Enrollment

75 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female
  • Adults (18 years or older)
  • Diagnosis of breast cancer-related lymphedema for a minimum of 3 months
  • No current evidence of active cancer
  • Able to provide informed consent

Exclusion criteria

  • Pre-existing musculoskeletal conditions affecting the upper extremities (e.g. adhesive capsulitis, rotator cuff tear)
  • Previous upper extremity surgery
  • Physical inability to perform the required physical movements and assessments

Trial design

75 participants in 3 patient groups

Mild lymphedema (stage 1)
Description:
International Society of Lymphology lymphedema severity stage 1, characterized by swelling with pitting, normal skin and tissue turgor. Participants assigned to this group will have mild swelling and tightness of the arm.
Treatment:
Other: Lymphedema severity stratification
Moderate lymphedema (stage 2)
Description:
International Society of Lymphology lymphedema severity stage 2, characterized by swelling with pitting as well as skin and tissue changes such as dermal thickening. Participants assigned to this group will have moderate swelling and tightness of the arm as well as skin changes without distortional warty-overgrowth or elephantiasis folds.
Treatment:
Other: Lymphedema severity stratification
Severe lymphedema (stage 3)
Description:
International Society of Lymphology lymphedema severity stage 3, characterized by swelling with non-pitting, and warty-overgrowth or elephantiasis folds of skin. Participants assigned to this group will have severe swelling and tightness of the arm with warty overgrowth of skin.
Treatment:
Other: Lymphedema severity stratification

Trial contacts and locations

1

Loading...

Central trial contact

Mohamed M ElMeligie, Ph.d

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems